Brugada Syndrome Clinical Trials

Find Brugada Syndrome Clinical Trials Near You

Longterm Outcome and Predictors for Recurrence After Medical and Interventional Treatment of Arrhythmias At the University Heart Center Hamburg

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The Long-term Outcome and Predictors for Recurrence after Medical and Interventional Treatment of Arrhythmias at the University Heart Center Hamburg (TRUST) study is an investor-initiated, single-center, prospective clinical cohort study including patients treated with cardiac arrhythmias or at high risk for cardiac arrhythmias. The design enables prospective, low-threshold, near complete inclusion of patients with arrhythmias treated at the UHZ. Collection of routine follow-up data, detailed procedural information and systematic biobanking will enable precise and robust phenotyping.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Cardiac arrhythmia, including congenital cardiac arrhythmia diagnosed at baseline or high risk for cardiac arrhythmia

• Age ≥ 18 years

• Written informed consent

• Ability to provide written informed consent in accordance with Good Clinical Practice and local legislation

Locations
Other Locations
Germany
University Hospital Hamburg-Eppendorf, University Heart and Vascular Center
RECRUITING
Hamburg
Contact Information
Primary
Julius Obergassel, MD
trust@uke.de
+49 (40) 7410 - 58320
Time Frame
Start Date: 2021-03-17
Estimated Completion Date: 2031-12-31
Participants
Target number of participants: 5000
Sponsors
Leads: Universitätsklinikum Hamburg-Eppendorf

This content was sourced from clinicaltrials.gov